Propanc Biopharma (PPCB) Total Non-Current Liabilities (2013 - 2026)
Propanc Biopharma's Total Non-Current Liabilities came in at $23,818 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 83.8% from $147,376 a year earlier.
Powered by 
Analysis
Propanc Biopharma (PPCB) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Going back to fiscal Q4 2013, Propanc Biopharma's Total Non-Current Liabilities data covers 46 quarters.
- Total Non-Current Liabilities carries a five-year compound annual growth rate of -62.1% (FY2021 to FY2026).
- Going back by fiscal year, Total Non-Current Liabilities was $147,376 in FY2025 (+151.3%), $58,642 in FY2024 (+204.2%), $19,278 in FY2023 (-54.4%) and $42,319 in FY2022 (-98.6%).
- The fiscal Q4 2026 figure represents the lowest quarterly Total Non-Current Liabilities since fiscal Q4 2023.
- Year-over-year, Total Non-Current Liabilities increased in four of the last seven quarters, with growth averaging 35.1%.
- The fastest year-over-year change in Total Non-Current Liabilities over five years came in fiscal Q4 2024 (growth of 204.2%), and the weakest in fiscal Q3 2023 (a decline of 99.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Propanc Biopharma | 595,565.74 | 595,565.74 | - | 23,818.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23,818.00 |
| Dec 31, 2025 | 35,249.00 |
| Sep 30, 2025 | 42,080.00 |
| Jun 30, 2025 | 147,376.00 |
| Mar 31, 2025 | 93,913.00 |
| Dec 31, 2024 | 82,328.00 |
| Sep 30, 2024 | 70,485.00 |
| Jun 30, 2024 | 58,642.00 |
| Mar 31, 2024 | 48,870.00 |
| Dec 31, 2023 | 43,255.00 |
| Sep 30, 2023 | 36,517.00 |
| Jun 30, 2023 | 19,278.00 |
| Mar 31, 2023 | 24,939.00 |
| Dec 31, 2022 | 30,885.00 |
| Sep 30, 2022 | 39,363.00 |
| Jun 30, 2022 | 42,319.00 |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 2.31 Mn |
| Jun 30, 2021 | 3.03 Mn |
API Access
Propanc Biopharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();